Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health Illnesses Post published:January 12, 2023 Post category:Press Release
FILAMENT HEALTH ANNOUNCES CEO YEAR END LETTER AND CHANGE TO BOARD OF DIRECTORS Post published:January 5, 2023 Post category:Press Release
FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE FOR PALLIATIVE CARE Post published:December 15, 2022 Post category:Press Release
FILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES Post published:December 1, 2022 Post category:Press Release
FILAMENT HEALTH ANNOUNCES PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION AND MENTAL HEALTH Post published:November 17, 2022 Post category:Press Release
FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS Post published:November 10, 2022 Post category:Press Release
FILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE Post published:October 13, 2022 Post category:Press Release
FILAMENT HEALTH AND ATMA JOURNEY CENTERS ANNOUNCE 14 SUBJECTS DOSED IN HEALTH CANADA-APPROVED PSILOCYBIN CLINICAL TRIAL Post published:September 1, 2022 Post category:Press Release
FILAMENT HEALTH APPOINTS NEW MEMBERS TO BOARD OF DIRECTORS AND ADVISORY COUNCIL Post published:August 25, 2022 Post category:Press Release
FILAMENT HEALTH ANNOUNCES EIGHTH PATENT ISSUANCE Post published:August 18, 2022 Post category:Press Release